Preoperative Staging and Dose Escalated Radiotherapy of Prostate Carcinoma With PET and MRI (Flucipro)

Flucipro clinical trial ( Identifier NCT02002455) evaluated potential of Fluorine-18 labeled L-leucine analogue 1-amino-3-fluorocyclobutane-1-carboxylic acid (FACBC) hybrid positron emission tomography/computed tomography (PET/CT) or magnetic resonance imaging (PET/MRI) and multiparametric MRI (mpMRI) to improve selection of patients for robot-assisted radical prostatectomy and intensity modulated and image guided radiotherapy (IMRT and IGRT).

Log in